BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Treatment
46 results:

  • 1. EXOSC5 maintains cancer stem cell activity in endometrial cancer by regulating the NTN4/integrin β1 signalling axis.
    Huang YH; Wang WL; Wang PH; Lee HT; Chang WW
    Int J Biol Sci; 2024; 20(1):265-279. PubMed ID: 38164180
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Exploration of the Mechanism of Kaempferol in the treatment of Cervical cancer-based on Metabolomics and Network Pharmacology.
    Cao DM; Liu T
    Curr Pharm Des; 2023; 29(36):2877-2890. PubMed ID: 38062663
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Alkaloids from
    Wan Q; Xu J; Zhu C; Liu X; Tu Y; Lei J; Yu J
    J Agric Food Chem; 2023 Jul; 71(27):10349-10360. PubMed ID: 37392181
    [No Abstract]    [Full Text] [Related]  

  • 4. E7050 Suppresses the Growth of Multidrug-Resistant Human uterine Sarcoma by Inhibiting Angiogenesis via Targeting of VEGFR2-Mediated Signaling Pathways.
    Huang TT; Chen CM; Lin SS; Lan YW; Cheng HC; Choo KB; Wang CC; Huang TH; Chong KY
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298555
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Casein kinase 1 controls the shuttling of epidermal growth factor receptor and estrogen receptor in endometrial carcinoma induced by breast cancer hormonal therapy: Relevance of GPER1/src.
    Hoang LN; Lee SJ
    Cell Signal; 2023 Aug; 108():110733. PubMed ID: 37257767
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Molecular profiling of TAM tyrosine kinase receptors and ligands in endometrial carcinoma: An in silico-study.
    Dilara Fatma Akin ; Özkan D
    Taiwan J Obstet Gynecol; 2023 Mar; 62(2):311-324. PubMed ID: 36965901
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Integrating network pharmacology approaches for the investigation of multi-target pharmacological mechanism of 6-shogaol against cervical cancer.
    Elasbali AM; Al-Soud WA; Mousa Elayyan AE; Al-Oanzi ZH; Alhassan HH; Mohamed BM; Alanazi HH; Ashraf MS; Moiz S; Patel M; Patel M; Adnan M
    J Biomol Struct Dyn; 2023; 41(23):14135-14151. PubMed ID: 36943780
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Deregulation of SPOP in cancer.
    Zhang H; Jin X; Huang H
    Cancer Res; 2023 Feb; 83(4):489-499. PubMed ID: 36512624
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Blockade of c-Met-Mediated Signaling Pathways by E7050 Suppresses Growth and Promotes Apoptosis in Multidrug-Resistant Human uterine Sarcoma Cells.
    Huang TT; Chen CM; Lan YW; Lin SS; Choo KB; Chong KY
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499211
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Redox Regulation of NOX Isoforms on FAK
    Kim YM; Muthuramalingam K; Cho M
    Cells; 2020 Jun; 9(6):. PubMed ID: 32604782
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Biological Impact of Ulipristal Acetate on Cellular Networks Regulating uterine Leiomyoma Growth.
    Tinelli A; Kosmas IP; Mynbaev OA; Malvasi A; Sparic R; Vergara D
    Curr Pharm Des; 2020; 26(3):310-317. PubMed ID: 31987017
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Bosutinib Acts as a Tumor Inhibitor via Downregulating src/NF-κB/Survivin Expression in HeLa Cells.
    Yu L; Guo W; Liu L; Zhang G; Zhang F; Qu Y; Liu Y; Li H; Li H
    Anat Rec (Hoboken); 2019 Dec; 302(12):2193-2200. PubMed ID: 31569304
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Shp2 expression is upregulated in cervical cancer, and Shp2 contributes to cell growth and migration and reduces sensitivity to cisplatin in cervical cancer cells.
    Cao M; Gao D; Zhang N; Duan Y; Wang Y; Mujtaba H; Wang Y
    Pathol Res Pract; 2019 Nov; 215(11):152621. PubMed ID: 31564571
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identification of Candidate Plasma Protein Biomarkers for Cervical cancer Using the Multiplex Proximity Extension Assay.
    Berggrund M; Enroth S; Lundberg M; Assarsson E; Stålberg K; Lindquist D; Hallmans G; Grankvist K; Olovsson M; Gyllensten U
    Mol Cell Proteomics; 2019 Apr; 18(4):735-743. PubMed ID: 30692274
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A window-of-opportunity clinical trial of dasatinib in women with newly diagnosed endometrial cancer.
    Duska LR; Petroni GR; Lothamer H; Faust W; Beumer JH; Christner SM; Mills AM; Fracasso PM; Parsons SJ
    Cancer Chemother Pharmacol; 2019 Mar; 83(3):473-482. PubMed ID: 30535536
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Vascular endothelial growth factor C promotes cervical cancer cell invasiveness via regulation of microRNA-326/cortactin expression.
    Cheng Y; Jiang S; Yuan J; Liu J; Simoncini T
    Gynecol Endocrinol; 2018 Oct; 34(10):853-858. PubMed ID: 29658350
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Progesterone Receptor Isoforms, Nuclear Corepressor-1 and Steroid Receptor Coactivator-1 and B-Cell Lymphoma 2 and Akt and Akt Phosphorylation Status in uterine Myomas after Ulipristal Acetate treatment: A Systematic Immunohistochemical Evaluation.
    Courtoy GE; Donnez J; Marbaix E; Barreira M; Luyckx M; Dolmans MM
    Gynecol Obstet Invest; 2018; 83(5):443-454. PubMed ID: 29227976
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Involvement of src signaling in the synergistic effect between cisplatin and digoxin on cancer cell viability.
    Pereira DG; Salgado MAR; Rocha SC; Santos HL; Villar JAFP; Contreras RG; Fontes CFL; Barbosa LA; Cortes VF
    J Cell Biochem; 2018 Apr; 119(4):3352-3362. PubMed ID: 29130514
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis.
    Musa J; Achenbach CJ; O'Dwyer LC; Evans CT; McHugh M; Hou L; Simon MA; Murphy RL; Jordan N
    PLoS One; 2017; 12(9):e0183924. PubMed ID: 28873092
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Gamma tocotrienol targets tyrosine phosphatase SHP2 in mammospheres resulting in cell death through RAS/ERK pathway.
    Gu W; Prasadam I; Yu M; Zhang F; Ling P; Xiao Y; Yu C
    BMC Cancer; 2015 Aug; 15():609. PubMed ID: 26315028
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.